Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function.

Studies from our laboratory have suggested a role for ferrous iron in the metabolism of arachidonic acid and demonstrated that inhibitors of prostaglandin synthesis exert their effect by complexing with the heme group of cyclooxygenase. Docosahexaenoic acid (DHA) is a potent competitive inhibitor of arachidonic acid metabolism by sheep vesicular gland prostaglandin synthetase. In this study we have evaluated the effect of exogenously added DHA on platelet function and arachidonic acid metabolism. DHA at 150 microM concentration inhibited aggregation of platelets to 450 microM arachidonic acid. At this concentration DHA also inhibited the second wave of the platelet response to the action of agonists such as epinephrine, adenosine diphosphate and thrombin. Inhibition induced by this fatty acid could be overcome by the agonists at higher concentrations. DHA inhibited the conversion of labeled arachidonic acid to thromboxane by intact, washed platelet suspensions. However, platelets in plasma incubated first with DHA then washed and stirred with labeled arachidonate generated as much thromboxane as control platelets. These results suggest that the polyenoic acids, if released in sufficient quantities in the vicinity of cyclooxygenase, could effectively compete for the heme site and inhibit the conversion of arachidonic acid.

[1]  W. Lands,et al.  Recent concepts on platelet function and dietary lipids in coronary thrombosis, vasospasm and angina. , 1980, Herz.

[2]  R. Hermus,et al.  The effect of a fish diet on serum lipids in healthy human subjects. , 1978, The American journal of clinical nutrition.

[3]  D. Aharony,et al.  Inhibition of platelet lipoxygenase by toluene-3,4-dithiol and other ferric iron chelators. , 1981, Prostaglandins and medicine.

[4]  H M Sinclair,et al.  The composition of the Eskimo food in north western Greenland. , 1980, The American journal of clinical nutrition.

[5]  J. White,et al.  Inhibition of ferrous iron induced oxidation of arachidonic acid by indomethacin. , 1979, Prostaglandins and medicine.

[6]  P. Needleman,et al.  Thromboxanes: selective biosynthesis and distinct biological properties. , 1976, Science.

[7]  W. Harris,et al.  Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. , 1982, Arteriosclerosis.

[8]  H. Sprecher,et al.  Synthesis of hydroxy fatty acids from 4, 7, 10, 13, 16, 19-[1-14C] docosahexaenoic acid by human platelets. , 1983, The Journal of biological chemistry.

[9]  P. G. Iatridis,et al.  Inhibition of aggregation of human platelets by 8,15-dihydroperoxides of 5,9,11,13-eicosatetraenoic and 9,11,13-eicosatrienoic acids , 1978 .

[10]  J. Vane,et al.  EICOSAPENTAENOIC ACID AND PREVENTION OF THROMBOSIS AND ATHEROSCLEROSIS? , 1978, The Lancet.

[11]  M. Hamberg.  Transformations of 5,8,11,14,17-eicosapentaenoic acid in human platelets. , 1980, Biochimica et biophysica acta.

[12]  F. ten Hoor,et al.  Fish oil feeding lowers thromboxane- and prostacyclin production by rat platelets and aorta and does not result in the formation of prostaglandin I3. , 1981, Prostaglandins.

[13]  J. Dyerberg,et al.  Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. , 2009, Acta medica Scandinavica.

[14]  J. White,et al.  The role of iron in prostaglandin synthesis: ferrous iron mediated oxidation of arachidonic acid. , 1978, Prostaglandins and medicine.

[15]  J. Kinsella,et al.  A new prostaglandin, C22-PGF4α, synthesized from docosahexaenoic acid (C22:6n3) by trout gill , 1981 .

[16]  T. Sanders,et al.  COD-LIVER OIL, PLATELET FATTY ACIDS, AND BLEEDING TIME , 1980, The Lancet.

[17]  J. Dyerberg,et al.  HÆMOSTATIC FUNCTION AND PLATELET POLYUNSATURATED FATTY ACIDS IN ESKIMOS , 1979, The Lancet.

[18]  J. White,et al.  Rapid return of cyclo-oxygenase active platelets in dogs after a single oral dose of aspirin. , 1981, Prostaglandins.

[19]  D. Aharony,et al.  Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid. , 1982, Biochimica et biophysica acta.

[20]  R. Magendie,et al.  History of a Case of Hydrophobia, treated at the Hotel Dieu at Paris, by an injection of water into the veins. , 1823 .

[21]  J. Perrin.  C3 STANDARDS , 1975, The Lancet.

[22]  R. Anderson,et al.  Lipids of ocular tissues. IV. A comparison of the phospholipids from the retina of six mammalian species. , 1970, Experimental Eye Research.

[23]  I. Morita,et al.  Effect of eicosapentaenoic acid on the platelet aggregation and composition of fatty acid in man. A double blind study. , 1983, Atherosclerosis.

[24]  W. Lands,et al.  The effect of dietary supplementation of fish oil on experimental myocardial infarction. , 1980, Prostaglandins.

[25]  B. Scherer,et al.  PLATELET-MEMBRANE FATTY ACIDS, PLATELET AGGREGATION, AND THROMBOXANE FORMATION DURING A MACKEREL DIET , 1980, The Lancet.

[26]  J. White,et al.  Effects of 2,2'-dipyridyl and related compounds on platelet prostaglandin synthesis and platelet function. , 1980, Biochimica et biophysica acta.

[27]  J. White,et al.  Platelet aggregation independent of ADP release or prostaglandin synthesis in patients with hermansky-Pudlak syndrome. , 1981, Prostaglandins and medicine.